Cargando…

Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer

BACKGROUND: The Nijmegen Breakage Syndrome is a chromosomal instability disorder characterized by microcephaly, growth retardation, immunodeficiency, and increased frequency of cancers. Familial studies on relatives of these patients indicated that they also appear to be at increased risk of cancer....

Descripción completa

Detalles Bibliográficos
Autores principales: Desjardins, Sylvie, Beauparlant, Joly Charles, Labrie, Yvan, Ouellette, Geneviève, Durocher, Francine
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702391/
https://www.ncbi.nlm.nih.gov/pubmed/19523210
http://dx.doi.org/10.1186/1471-2407-9-181
_version_ 1782168774196068352
author Desjardins, Sylvie
Beauparlant, Joly Charles
Labrie, Yvan
Ouellette, Geneviève
Durocher, Francine
author_facet Desjardins, Sylvie
Beauparlant, Joly Charles
Labrie, Yvan
Ouellette, Geneviève
Durocher, Francine
author_sort Desjardins, Sylvie
collection PubMed
description BACKGROUND: The Nijmegen Breakage Syndrome is a chromosomal instability disorder characterized by microcephaly, growth retardation, immunodeficiency, and increased frequency of cancers. Familial studies on relatives of these patients indicated that they also appear to be at increased risk of cancer. METHODS: In a candidate gene study aiming at identifying genetic determinants of breast cancer susceptibility, we undertook the full sequencing of the NBN gene in our cohort of 97 high-risk non-BRCA1 and -BRCA2 breast cancer families, along with 74 healthy unrelated controls, also from the French Canadian population. In silico programs (ESEfinder, NNSplice, Splice Site Finder and MatInspector) were used to assess the putative impact of the variants identified. The effect of the promoter variant was further studied by luciferase gene reporter assay in MCF-7, HEK293, HeLa and LNCaP cell lines. RESULTS: Twenty-four variants were identified in our case series and their frequency was further evaluated in healthy controls. The potentially deleterious p.Ile171Val variant was observed in one case only. The p.Arg215Trp variant, suggested to impair NBN binding to histone γ-H2AX, was observed in one breast cancer case and one healthy control. A promoter variant c.-242-110delAGTA displayed a significant variation in frequency between both sample sets. Luciferase reporter gene assay of the promoter construct bearing this variant did not suggest a variation of expression in the MCF-7 breast cancer cell line, but indicated a reduction of luciferase expression in both the HEK293 and LNCaP cell lines. CONCLUSION: Our analysis of NBN sequence variations indicated that potential NBN alterations are present, albeit at a low frequency, in our cohort of high-risk breast cancer cases. Further analyses will be needed to fully ascertain the exact impact of those variants on breast cancer susceptibility, in particular for variants located in NBN promoter region.
format Text
id pubmed-2702391
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27023912009-06-27 Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer Desjardins, Sylvie Beauparlant, Joly Charles Labrie, Yvan Ouellette, Geneviève Durocher, Francine BMC Cancer Research Article BACKGROUND: The Nijmegen Breakage Syndrome is a chromosomal instability disorder characterized by microcephaly, growth retardation, immunodeficiency, and increased frequency of cancers. Familial studies on relatives of these patients indicated that they also appear to be at increased risk of cancer. METHODS: In a candidate gene study aiming at identifying genetic determinants of breast cancer susceptibility, we undertook the full sequencing of the NBN gene in our cohort of 97 high-risk non-BRCA1 and -BRCA2 breast cancer families, along with 74 healthy unrelated controls, also from the French Canadian population. In silico programs (ESEfinder, NNSplice, Splice Site Finder and MatInspector) were used to assess the putative impact of the variants identified. The effect of the promoter variant was further studied by luciferase gene reporter assay in MCF-7, HEK293, HeLa and LNCaP cell lines. RESULTS: Twenty-four variants were identified in our case series and their frequency was further evaluated in healthy controls. The potentially deleterious p.Ile171Val variant was observed in one case only. The p.Arg215Trp variant, suggested to impair NBN binding to histone γ-H2AX, was observed in one breast cancer case and one healthy control. A promoter variant c.-242-110delAGTA displayed a significant variation in frequency between both sample sets. Luciferase reporter gene assay of the promoter construct bearing this variant did not suggest a variation of expression in the MCF-7 breast cancer cell line, but indicated a reduction of luciferase expression in both the HEK293 and LNCaP cell lines. CONCLUSION: Our analysis of NBN sequence variations indicated that potential NBN alterations are present, albeit at a low frequency, in our cohort of high-risk breast cancer cases. Further analyses will be needed to fully ascertain the exact impact of those variants on breast cancer susceptibility, in particular for variants located in NBN promoter region. BioMed Central 2009-06-12 /pmc/articles/PMC2702391/ /pubmed/19523210 http://dx.doi.org/10.1186/1471-2407-9-181 Text en Copyright ©2009 Desjardins et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Desjardins, Sylvie
Beauparlant, Joly Charles
Labrie, Yvan
Ouellette, Geneviève
Durocher, Francine
Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer
title Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer
title_full Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer
title_fullStr Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer
title_full_unstemmed Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer
title_short Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer
title_sort variations in the nbn/nbs1 gene and the risk of breast cancer in non-brca1/2 french canadian families with high risk of breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702391/
https://www.ncbi.nlm.nih.gov/pubmed/19523210
http://dx.doi.org/10.1186/1471-2407-9-181
work_keys_str_mv AT desjardinssylvie variationsinthenbnnbs1geneandtheriskofbreastcancerinnonbrca12frenchcanadianfamilieswithhighriskofbreastcancer
AT beauparlantjolycharles variationsinthenbnnbs1geneandtheriskofbreastcancerinnonbrca12frenchcanadianfamilieswithhighriskofbreastcancer
AT labrieyvan variationsinthenbnnbs1geneandtheriskofbreastcancerinnonbrca12frenchcanadianfamilieswithhighriskofbreastcancer
AT ouellettegenevieve variationsinthenbnnbs1geneandtheriskofbreastcancerinnonbrca12frenchcanadianfamilieswithhighriskofbreastcancer
AT variationsinthenbnnbs1geneandtheriskofbreastcancerinnonbrca12frenchcanadianfamilieswithhighriskofbreastcancer
AT durocherfrancine variationsinthenbnnbs1geneandtheriskofbreastcancerinnonbrca12frenchcanadianfamilieswithhighriskofbreastcancer